These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 9374335)

  • 1. Benzodiazepine receptors in chronic cerebrovascular disease: comparison with blood flow and metabolism.
    Sasaki M; Ichiya Y; Kuwabara Y; Yoshida T; Fukumura T; Masuda K
    J Nucl Med; 1997 Nov; 38(11):1693-8. PubMed ID: 9374335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cerebral infarction with iodine 123-iomazenil SPECT.
    Hatazawa J; Satoh T; Shimosegawa E; Okudera T; Inugami A; Ogawa T; Fujita H; Noguchi K; Kanno I; Miura S
    J Nucl Med; 1995 Dec; 36(12):2154-61. PubMed ID: 8523097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative estimation of I-123-Iomazenil receptor binding in temporal lobe epilepsies using two SPECT acquisitions--comparison with the regional cerebral blood flow and a compartment model.
    Venz S; Hierholzer J; Cordes M; Straub HB; Keske U; Meencke HJ; Eichstädt H; Felix R
    Nuklearmedizin; 1998 Mar; 37(2):49-56. PubMed ID: 9547750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iodine-123-iomazenil and iodine-123-iodoamphetamine SPECT in major cerebral artery occlusive disease.
    Moriwaki H; Matsumoto M; Hashikawa K; Oku N; Ishida M; Seike Y; Fukuchi K; Hori M; Nishimura T
    J Nucl Med; 1998 Aug; 39(8):1348-53. PubMed ID: 9708504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of iodine-123-iomazenil SPECT and technetium-99m-HMPAO-SPECT in Alzheimer's disease.
    Fukuchi K; Hashikawa K; Seike Y; Moriwaki H; Oku N; Ishida M; Fujita M; Uehara T; Tanabe H; Kusuoka H; Nishimura T
    J Nucl Med; 1997 Mar; 38(3):467-70. PubMed ID: 9074540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Benzodiazepine receptor and cerebral blood flow in early Alzheimer's disease--SPECT study using 123I-iomazenil and 123I-IMP].
    Kitamura S; Koshi Y; Komiyama T; Sakayori O; Komaba Y; Ohyama M; Mishina M; Tsuganesawa T; Terashi A
    Kaku Igaku; 1996 Jan; 33(1):49-56. PubMed ID: 8819714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A phase 3 clinical trial of 123I-iomazenil, a new central-type benzodiazepine receptor imaging agent (Part 4)--Report on clinical usefulness in diagnosis of cerebrovascular diseases].
    Torizuka K; Uemura K; Toru M; Shinohara Y; Nishimura T; Yonekura Y; Nakagawara J; Matsuda H; Sakai F; Matsuda K; Fukuyama H; Morimoto K
    Kaku Igaku; 1996 Mar; 33(3):329-44. PubMed ID: 8622266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of benzodiazepine receptors using iodine-123-labeled iomazenil single-photon emission computed tomography in patients with ischemic cerebrovascular disease. A comparison with PET study.
    Dong Y; Fukuyama H; Nabatame H; Yamauchi H; Shibasaki H; Yonekura Y
    Stroke; 1997 Sep; 28(9):1776-82. PubMed ID: 9303025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Compartment analysis of 123I-iomazenil brain on early and delayed SPECT].
    Yanagimoto S; Ono S; Sone T; Morita K; Nagai K; Otsuka N; Mimura H; Tomomitsu T; Fukunaga M; Muranaka A; Itaya M; Kitayama A
    Kaku Igaku; 1997 Jun; 34(6):371-7. PubMed ID: 9267122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of early and late images on 123I-iomazenil SPECT with cerebral blood flow and oxygen extraction fraction images on PET in the cerebral cortex of patients with chronic unilateral major cerebral artery occlusive disease.
    Suzuki T; Ogasawara K; Kuroda H; Chida K; Aso K; Kobayashi M; Fujiwara S; Yoshida K; Terasaki K; Ogawa A
    Nucl Med Commun; 2012 Feb; 33(2):171-8. PubMed ID: 22095318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with 123I-iomazenil SPECT in acute cerebral infarction.
    Müller V; Saur D; Klutmann S; Weiller C; Röther J; Clausen M
    Nucl Med Commun; 2002 Dec; 23(12):1191-6. PubMed ID: 12464784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the addition of
    Ogasawara K; Takahashi T; Igarashi S; Yabuki M; Omori D; Akamatsu Y; Chida K; Kobayashi M; Fujiwara S; Terasaki K
    Ann Nucl Med; 2023 May; 37(5):280-288. PubMed ID: 36805493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of outcome by EC/IC bypass with 123I-iomazenil brain SPECT.
    Makino K; Kamiyama H; Takamura H; Gotoh S; Kobayashi N
    Ann Nucl Med; 1999 Aug; 13(4):261-4. PubMed ID: 10510883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of cerebral benzodiazepine receptor distribution in epilepsy by 123I-iomazenil-SPECT].
    Uchiyama M; Sue H; Fukumitsu N; Mori Y; Kawakami K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Jan; 57(1):47-51. PubMed ID: 9038063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assessment of cerebral benzodiazepine receptor distribution in anxiety disorders by 123I-iomazenil-SPECT: comparison to cerebral perfusion scintigraphy by 123I-IMP].
    Uchiyama M; Sue H; Fukumitsu N; Mori Y; Kawakami K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Jan; 57(1):41-6. PubMed ID: 9038062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phase 2 clinical study of 123I-iomazenil in various cerebral diseases: part 1--examination of injection dose and clinical indications].
    Torizuka K; Uemura K; Tohru M; Yonekura Y; Nakagawara J; Fukuyama H; Matsuda K; Morimoto K
    Kaku Igaku; 1996 Feb; 33(2):179-90. PubMed ID: 8721107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetries of benzodiazepine receptor binding potential in the inferior medial temporal lobe and cerebellum detected with 123I-iomazenil SPECT in comparison with 99mTc-HMPAO SPECT in patients with partial epilepsy.
    Kuji I; Sumiya H; Tsuji S; Ichikawa A; Tonami N
    Ann Nucl Med; 1998 Aug; 12(4):185-90. PubMed ID: 9795703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofixation and hyperfixation of 99mTc-hexamethyl propyleneamine oxime in subacute cerebral infarction.
    Ogasawara K; Ogawa A; Koshu K; Konno H; Suzuki M; Yoshimoto T
    J Nucl Med; 2000 May; 41(5):795-9. PubMed ID: 10809194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain SPECT imaging using three different tracers in subacute cerebral infarction.
    Hashimoto J; Sasaki T; Itoh Y; Nakamura K; Kubo A; Amano T; Fukuuchi Y
    Clin Nucl Med; 1998 May; 23(5):275-7. PubMed ID: 9596150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of reduction of cortical blood flow in striatocapsular infarction: studies using [123I]iomazenil SPECT.
    Takahashi W; Ohnuki Y; Ohta T; Hamano H; Yamamoto M; Shinohara Y
    Neuroimage; 1997 Aug; 6(2):75-80. PubMed ID: 9299381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.